APTEVO THERAPEUTICS INC - COM NEW (APVO)

CUSIP: 03835L207

Q2 2023 13F Holders as of 30 Jun 2023

Type / Class
Equity / COM NEW
Total 13F shares
928,804
Share change
+37,208
Total reported value
$1,359,729
Price per share
$1.46
Number of holders
23
Value change
+$34,650
Number of buys
5
Number of sells
5

Quarterly Holders Quick Answers

What is CUSIP 03835L207?
CUSIP 03835L207 identifies APVO - APTEVO THERAPEUTICS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of APTEVO THERAPEUTICS INC - COM NEW (APVO) as of Q2 2023

As of 30 Jun 2023, APTEVO THERAPEUTICS INC - COM NEW (APVO) was held by 23 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 928,804 shares. The largest 10 holders included CANTOR FITZGERALD, L. P., VANGUARD GROUP INC, Schonfeld Strategic Advisors LLC, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, BlackRock Inc., PRICE T ROWE ASSOCIATES INC /MD/, NORTHERN TRUST CORP, CITADEL ADVISORS LLC, and MORGAN STANLEY. This page lists 23 institutional shareholders reporting positions in this security for the Q2 2023 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.